SCHEMBL2974759

SCHEMBL2974759

Cc1ccoc1[C]1C=Cc2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRC P08575 2/20 0.36
ADRA1A P35348 3/20 0.35
ADRA1D P25100 2/20 0.35
ADRA1B P35368 1/20 0.35
LMNA P02545 3/20 0.34
ALDH1A1 P00352 2/20 0.34
HSD17B10 Q99714 2/20 0.34
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.34
ALOX15 P16050 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 1/20 0.34
BCHE P06276 1/20 0.34
POLB P06746 1/20 0.34
THRB P10828 1/20 0.34
PKM P14618 1/20 0.34
IDO1 P14902 1/20 0.34
HPGD P15428 1/20 0.34
PTPN1 P18031 1/20 0.34
ACHE P22303 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2975145 0.80 PTPRC (0.36) PTPRCADRA1ALMNAALDH1A1HSD17B10
SCHEMBL2971429 0.77 SETD7 (0.31) PTPRCSETD7
SCHEMBL2966274 0.76 ALDH1A1 (0.33) PTPRCADRA1AADRA1DLMNAALDH1A1
SCHEMBL2966545 0.75 PTPRC (0.34) PTPRCADRA1AADRA1DADRA1BGRM1
SCHEMBL2974083 0.75 SETD7 (0.34) SETD7
SCHEMBL23567051 0.74 NPC1 (0.43) PTPRCADRA1AADRA1DADRA1BALDH1A1
SCHEMBL2968620 0.74 ADRA1D (0.39) PTPRCADRA1AADRA1DADRA1BGRM1
SCHEMBL5921807 0.72 LMNA (0.50) PTPRCADRA1AADRA1DLMNAALDH1A1
SCHEMBL2966543 0.71 PTPRC (0.34) PTPRCADRA1AADRA1DADRA1BGRM1
SCHEMBL216367 0.71 ALDH1A1 (0.41) PTPRCADRA1AADRA1DLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276567-B2 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-10-02 US claimed
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-7276567-B2 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-10-02 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
US-7214747-B2 Phosphorus substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-05-08 US disclosed
US-7214746-B2 Phosphorus bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-05-08 US disclosed
US-20050261449-A1 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENT INC. 2005-11-24 US disclosed
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2005-10-27 US disclosed
US-20050239980-A1 Phosphorus substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization PYM1, ZNF207, POLL PTPRC 281/4885ADRA1A 3653/4885ADRA1D 3761/4885
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 PTPRC 3821/4885ADRA1A 2301/4885ADRA1D 2782/4885
US-20050239980-A1 Phosphorus substituted metallocene compounds for olefin polymerization CCRL2, ARL1, OSBP2 PTPRC 428/4885ADRA1A 2896/4885ADRA1D 3346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.